Evidence map›Paper›PMID 36148221›Full record

ArticleFrontiers in immunology2022

Initial activation of STAT2 induced by IAV infection is critical for innate antiviral immunity.

Xinxin Li, Siya Liu, Kul Raj Rai, Wenzhuo Zhou, Song Wang, Xiaojuan Chi, Guijie Guo, Ji-Long Chen, Shasha Liu

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.7field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 10 citations in OpenAlex.

  1. Viral mimicry may help explain immunogenic cell death.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Xinxin LiFujian Agriculture and Forestry University, Fuzhou, China.
Siya LiuFujian Agriculture and Forestry University, Fuzhou, China.
Kul Raj RaiFujian Agriculture and Forestry University, Fuzhou, China.
Wenzhuo ZhouFujian Agriculture and Forestry University, Fuzhou, China.
Song WangFujian Agriculture and Forestry University, Fuzhou, China.
Xiaojuan ChiFujian Agriculture and Forestry University, Fuzhou, China.
Guijie GuoFujian Agriculture and Forestry University, Fuzhou, China.
Ji-Long ChenFujian Agriculture and Forestry University, Fuzhou, China.
Shasha LiuFujian Agriculture and Forestry University, Fuzhou, China.
Fujian Agriculture and Forestry University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

STAT2 is an important transcription factor activated by interferons (IFNs) upon viral infection and plays a key role in antiviral responses. Interestingly, here we found that phosphorylation of STAT2 could be induced by several viruses at early infection stage, including influenza A virus (IAV), and such initial activation of STAT2 was independent of type I IFNs and JAK kinases. Furthermore, it was observed that the early activation of STAT2 during viral infection was mainly regulated by the RIG-I/MAVS-dependent pathway. Disruption of STAT2 phosphorylation at Tyr690 restrained antiviral response, as silencing STAT2 or blocking STAT2 Y690 phosphorylation suppressed the expression of several interferon-stimulated genes (ISGs), thereby facilitating viral replication.

Indexed as

Influenza A virusInfluenza, HumanInterferon Type IHumansJanus KinasesSTAT2 Transcription FactorInterferon Type IJanus KinasesSTAT2 protein, humanSTAT2 Transcription Factorinfluenza virusinnate immunitykinaseMAPK12STAT2

Identifiers

PMID36148221
PMCPMC9486978
OpenAlexW4294605441

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.